Preparation and evaluation of an Emulgel of Hydroxyzine hydrochloride

P. Lakshmi, K. Mounika, K. Kalyani
{"title":"Preparation and evaluation of an Emulgel of Hydroxyzine hydrochloride","authors":"P. Lakshmi, K. Mounika, K. Kalyani","doi":"10.21276/IJRDPL.2278-0238.2018.7(2).2962-2968","DOIUrl":null,"url":null,"abstract":"http://dx.doi.org/10.21276/IJRDPL.22780238.2018.7(2).2962-2968 ABSTRACT: Hydroxyzine hydrochloride is effective in the treatment of urticaria and other allergic skin disorders. Hydroxyzine hydrochloride emulgel potentially enhances drug penetration into the stratum corneum and localizes the drug within the dermoepidermal layers. Emulgel was formulated by first preparing the emulsion using fixed oils and non-ionic surfactants, and then incorporated into a gel base. Emulsions were primarily optimized using non-ionic surfactants, Span 60 and Tween 20 and gel was optimized using Carbopol 940, HPMC K100M and xanthan gum. These optimized formulations were studied for in vitro drug release studies followed by ex vivo, skin irritation and stability studies. The optimized o/w emulgel was compared with the w/o emulgel which showed the in vitro release of 76.7% and ex vivo studies showed 42.3% release at the end of 8th hr. The ex vivo release of optimized HESX (o/w emulgel) formulation was compared with the HESX1 (w/o emulgel) formulation which showed the release of 53% and 42.3% release respectively. The emulgel formulation HESX showed irritation potential of ‘0’, thus proving to be non-irritant. Hence, it can be concluded that o/w emulgel formulation of hydroxyzine hydrochloride showed better release than the w/o emulgel.","PeriodicalId":14206,"journal":{"name":"International Journal of Research and Development in Pharmacy and Life Sciences","volume":"7 1","pages":"2962-2968"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research and Development in Pharmacy and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21276/IJRDPL.2278-0238.2018.7(2).2962-2968","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

http://dx.doi.org/10.21276/IJRDPL.22780238.2018.7(2).2962-2968 ABSTRACT: Hydroxyzine hydrochloride is effective in the treatment of urticaria and other allergic skin disorders. Hydroxyzine hydrochloride emulgel potentially enhances drug penetration into the stratum corneum and localizes the drug within the dermoepidermal layers. Emulgel was formulated by first preparing the emulsion using fixed oils and non-ionic surfactants, and then incorporated into a gel base. Emulsions were primarily optimized using non-ionic surfactants, Span 60 and Tween 20 and gel was optimized using Carbopol 940, HPMC K100M and xanthan gum. These optimized formulations were studied for in vitro drug release studies followed by ex vivo, skin irritation and stability studies. The optimized o/w emulgel was compared with the w/o emulgel which showed the in vitro release of 76.7% and ex vivo studies showed 42.3% release at the end of 8th hr. The ex vivo release of optimized HESX (o/w emulgel) formulation was compared with the HESX1 (w/o emulgel) formulation which showed the release of 53% and 42.3% release respectively. The emulgel formulation HESX showed irritation potential of ‘0’, thus proving to be non-irritant. Hence, it can be concluded that o/w emulgel formulation of hydroxyzine hydrochloride showed better release than the w/o emulgel.
盐酸羟嗪乳状液的制备及评价
http://dx.doi.org/10.21276/IJRDPL.22780238.2018.7(2).2962-2968摘要:盐酸羟嗪是治疗荨麻疹等过敏性皮肤病的有效药物。盐酸羟嗪乳凝胶有可能增强药物对角质层的渗透,并将药物定位在真皮表皮层内。首先用固定油和非离子表面活性剂制备乳液,然后将其掺入凝胶基中配制成乳液。乳液主要采用非离子表面活性剂Span 60和Tween 20进行优化,凝胶主要采用Carbopol 940、HPMC K100M和黄原胶进行优化。这些优化的配方进行了体外药物释放研究,随后进行了离体、皮肤刺激和稳定性研究。将优化后的0 /w乳凝胶与w/o乳凝胶进行比较,其体外释放量为76.7%,体外释放量为42.3%。将优化后的HESX (w/ w凝胶)制剂与HESX1 (w/o凝胶)制剂的体外释放度进行比较,两者的体外释放度分别为53%和42.3%。凝胶制剂HESX的刺激电位为“0”,证明其无刺激性。由此可见,盐酸羟嗪的0 /w乳剂比w/o乳剂具有更好的释放效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信